Intellia Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-67.5M | $-31.6M | $-12.4M |
| Depreciation & Amortization | $3.0M | $1.1M | $328.0K |
| Depreciation | $3.0M | $1.1M | $300.0K |
| Amortization | — | — | — |
| Stock-Based Compensation | $15.3M | $6.7M | $1.3M |
| Net Cash from Operating Activities | $-65.3M | $36.1M | $-1.8M |
| Investing Activities | |||
| Capital Expenditures | $10.1M | $6.2M | $2.6M |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $-10.1M | $-6.2M | — |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $143.0M | $167.3M | — |
| Net Change in Cash | $67.6M | $197.2M | $66.0M |
| Free Cash Flow | $-75.4M | $29.9M | $-4.3M |